Key Facts

  • Lilly at a Glance

    • A heritage more than 140 years strong: company founded on May 10, 1876
    • Headquarters located in Indianapolis, Indiana, U.S.A.
    • Approximately 33,000 employees worldwide
    • More than 7,700 employees engaged in research and development
    • Clinical research conducted in more than 55 countries
    • Research and development facilities located in 8 countries
    • Manufacturing plants located in 8 countries
    • Products marketed in 120 countries
  • Employees

    (as of September 30, 2019)

    • Indianapolis: 10,764
    • Indiana (excluding Indianapolis): 81
    • U.S. (excluding Indiana): 3,795
    • Outside U.S.: 19,269
    • Worldwide total: 33,909
  • 2018 Financials

    (dollars in millions, except per-share data)

    • Net sales: $24,555.7
    • Net income as reported: $3,232.0
    • Net income non-GAAP: $5,734.6
    • Earnings per share as reported: $3.13
    • Earnings per share non-GAAP: $5.55
    • Dividends paid per share: $2.25
  • Research & Development

    2018 Expenditures

    • $5,307 million/year
    • $20 million/workday
    • R&D as a percentage of sales: 21.6%
    • Employees engaged in R&D activities: 7,742
    • Percentage of total workforce: 23%
  • Cost of Pharmaceuticals

    • Average cost to discover and develop a new drug: $2.6 billion
    • Average length of time from discovery to patient: 10 years